Corline Biomedical: Kardium receives FDA approval - Redeye

Redeye is positive about Kardium’s FDA approval for the Globe system, which allows the commercial phase to begin. As our previous sales projections were risk-adjusted, we now make some changes to our forecasts. These revisions result in an updated fair value range for Corline.

Länk till analysen i sin helhet: https://www.redeye.se/research/1126259/corline-biomedical-kardium-receives-fda-approval?utm_source=finwire&utm_medium=RSS